WCOE: Genetic Testing for Cancer Survivors, Survivorship as a ‘Chronic Condition,’ Post-Treatment Neuropathy, Moonshot Funding
| What Caught Our Eye (WCOE) Each week, we recap the cancer policy articles, studies, and stories that caught our attention. |
Insurer's approval of genetic testing for some cancers raises questions https://t.co/zxk1j3y7EG via @usatoday
— NCCS – National Coalition for Cancer Survivorship (@CancerAdvocacy) February 3, 2016
Important question: Is Cancer Survivorship a 'Complex Chronic Condition'? https://t.co/KxBYz3kAaS via @HPLifestyle
— NCCS – National Coalition for Cancer Survivorship (@CancerAdvocacy) February 3, 2016
Persistent Peripheral Neuropathy Increases Fall Risk among Cancer Survivors https://t.co/Boa0MxnlzU #survivorship pic.twitter.com/x3gxWoRScL
— National Cancer Institute (@theNCI) February 5, 2016
White House To Request $1 Billion For Cancer 'Moonshot' https://t.co/aJINvsfQpY
— NPR Health News (@NPRHealth) February 1, 2016
Smita Bhatia talks to @oncnursingnews about those who develop 2nd cancers after original treatment: https://t.co/S6aVSpKKDy
— NCCS – National Coalition for Cancer Survivorship (@CancerAdvocacy) February 4, 2016
Follow us on Twitter: @canceradvocacy
